COVID-19 Survival and its impact on chronic kidney disease

JD Long, IAN Strohbehn, R Sawtell… - Translational …, 2022 - Elsevier
Up to 87% of patients hospitalized with coronavirus disease 2019 (COVID-19) experience
chronic sequelae following infection. The long-term impact of COVID-19 infection on kidney …

The roles of methylprednisolone treatment in patients with COVID-19: A systematic review and meta-analysis

S Hong, H Wang, Z Zhang, L Qiao - Steroids, 2022 - Elsevier
The roles of methylprednisolone in treatment of patients with COVID-19 remain unclear. The
aim of this study was to evaluate the efficacy and safety of methylprednisolone in treatment …

[HTML][HTML] Efficacy and safety of corticosteroid use in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis

Y Cui, Y Sun, J Sun, H Liang, X Ding, X Sun… - Infectious Diseases and …, 2021 - Springer
Introduction We conducted a comprehensive literature review to synthesize evidence for the
relationship between corticosteroid use and mortality in patients with COVID-19. Methods …

Efficacy and safety of corticosteroid regimens for the treatment of hospitalized COVID-19 patients: a meta-analysis

F Zhou, J Deng, K Heybati, QK Zuo, S Ali, W Hou… - Future …, 2022 - Taylor & Francis
Aim: To evaluate the efficacy and safety of corticosteroids for treating hospitalized COVID-19
patients. Materials & methods: Efficacy outcomes included time to negative SARS-CoV-2 …

Immunosuppressants against acute kidney injury: what to prefer or to avoid?

S Mishra, V Shelke, N Dagar, M Lech… - Immunopharmacology …, 2024 - Taylor & Francis
Background Acute kidney injury (AKI) is a critical global health issue associated with high
mortality rates, particularly in patients undergoing renal transplants and major surgeries …

Bioinformatics and systems-biology approach to identify common pathogenic mechanisms for COVID-19 and systemic lupus erythematosus

Y Wu, Y Li, Y Zhou, X Bai, Y Liu - Autoimmunity, 2024 - Taylor & Francis
Abstract Background The Coronavirus disease 2019 (COVID-19) pandemic has brought a
heavy burden to the world, interestingly, it shares many clinical symptoms with systemic …

[HTML][HTML] The role of methylprednisolone in severe COVID-19 patients: a meta-analysis

W Xu, Y Zeng, H Han, T Lv, D Lin - Frontiers in Medicine, 2024 - frontiersin.org
Background The purpose of this study is to assess the effectiveness of methylprednisolone
in severe COVID-19. Methods PubMed, the Cochrane Library and Web of Science were …

[HTML][HTML] Heterogeneity and risk of bias in studies examining risk factors for severe illness and death in COVID-19: a systematic review and meta-analysis

A Degarege, Z Naveed, J Kabayundo, D Brett-Major - Pathogens, 2022 - mdpi.com
This systematic review and meta-analysis synthesized the evidence on the impacts of
demographics and comorbidities on the clinical outcomes of COVID-19, as well as the …

[HTML][HTML] Acute Kidney Injury Associated with Severe SARS-CoV-2 Infection: Risk Factors for Morbidity and Mortality and a Potential Benefit of Combined Therapy with …

J Iglesias, A Vassallo, J Ilagan, SP Ang, N Udongwo… - Biomedicines, 2023 - mdpi.com
Background: Acute kidney injury (AKI) is a common complication in patients with severe
COVID-19. Methods: We retrospectively reviewed 249 patients admitted to an intensive care …

Acute Kidney Injury in Covid-19 Infection: A Qualitative Review of Literature

XM Lim, CTS Lim - Journal of Clinical and Translational …, 2022 - jctn.msn.org.my
COVID-19 is a coronavirus infection of the respiratory system, with multiorgan involvement.
Acute kidney injury (AKI) is one of the complications of covid-19 infection. This review …